Skip to main content

HEALTH

  • Pharmavite launches four new supplements

    NORTHRIDGE, Calif. — Pharmavite launched four new products onto retail shelves in March, including two gummy vitamins, an immune-system booster and an omega-3 supplement.

    "We strive to develop products that meet consumers' needs, and the breadth of our new product line up this year is no exception to this commitment," stated Tim Toll, chief customer officer at Pharmavite. "As a leading brand in the vitamin and supplement industry, we take pride in developing quality products that help consumers meet their daily nutritional needs."

  • Osato International brings papaya-based immunity booster to U.S.

    LOS ANGELES — Osato International recently brought Immun’Âge, a fermented papaya preparation, to the U.S. market. According to Osato, the superfood supplement helps boost the immune system and serves as an antioxidant.

  • Greater number of allergy sufferers turn to OTC solutions, CHPA, Nielsen study finds

    WASHINGTON — New research from the Consumer Healthcare Products Association and Nielsen released Thursday indicated that more Americans are suffering from seasonal allergies and are choosing nonprescription treatments over prescription medications.

  • Flu season still 'Texas big' in Lone Star State

    DEERFIELD, Ill. — The Lone Star State remains the chief hold out with regard to extending a flu season that's been winding down. According to the latest Walgreens Flu Index, four of the top 10 markets still experiencing high levels of flu activity are in Texas, including three of the top five markets.

    For the week of March 12, the top 10 markets for flu activity were:

  • Not enough hip-fracture patients are supplementing with vitamin D, AAOS finds

    ROSEMONT, Ill. — Despite national recommendations for daily vitamin D intake, a new study presented Tuesday at the 2017 Annual Meeting of the American Academy of Orthopaedic Surgeons found that just 45.7% of patients reported consistently taking vitamin D supplements following a hip fracture, a known treatment and preventative strategy for osteoporosis.

  • Researchers from Johns Hopkins Medicine recommend OTC availability for contraceptives

    BALTIMORE — Researchers from Johns Hopkins Medicine on Tuesday made the case for the Rx-to-OTC switch of oral contraceptives.

    Moreover, the experts reported, the evidence also supports OTC access for teens and adult women, citing studies showing that teens are capable of safely and properly using "the pill" to prevent unwanted pregnancies.

  • IRI, Experian establish better marketing ROI through partnership

    CHICAGO — IRI on Monday partnered with Experian on a initiative designed to drive a better return on advertising spend for marketers and improve shopping experiences.

    The joint effort enables marketers to leverage IRI ProScores, an audience targeting solution built from household purchase data. As part of the agreement, Experian’s clients will have direct access to IRI ProScores.

X
This ad will auto-close in 10 seconds